Sign In
Buy VRAX
$0.155
-0.0081 (-4.97%)
At Close: Jun 23, 2026
Virax Biolabs to Participate at 7th European Congress of Immunology
09:03am, Thursday, 29'th Aug 2024
LONDON , Aug. 29, 2024 /PRNewswire/ -- Virax Biolabs Group Limited ("Virax" or the "Company") (Nasdaq: VRAX), an innovative biotechnology company focused on the detection of immune responses and diag
Virax Biolabs stock soars 45% on Mpox detection kit deal: What you need to know
02:18pm, Wednesday, 28'th Aug 2024
Virax Biolabs Group Ltd (NASDAQ: VRAX) saw its shares surge by approximately 45% on Wednesday after announcing a partnership with a leading supplier of Mpox detection kits. The partnership grants Vira
LONDON , Aug. 28, 2024 /PRNewswire/ -- Virax Biolabs Group Limited (NASDAQ: VRAX) ("Virax" or the "Company"), an innovative biotechnology company focused on the detection of immune responses and diagn
Virax Biolabs Group Limited Announces Closing of $5 Million Registered Direct Offering of Ordinary Shares
04:09pm, Friday, 23'rd Aug 2024
LONDON , Aug. 23, 2024 /PRNewswire/ -- Virax Biolabs Group Limited ("Virax" or the "Company") (Nasdaq: VRAX), an innovative biotechnology company focused on the detection of immune responses and diagn
Virax Biolabs Group Limited Announces $5 Million Registered Direct Offering of Ordinary Shares
09:30pm, Wednesday, 21'st Aug 2024
LONDON , Aug. 21, 2024 /PRNewswire/ -- Virax Biolabs Group Limited ("Virax" or the "Company") (Nasdaq: VRAX), an innovative biotechnology company focused on the detection of immune responses and diagn
Cosmos Health Holds EU Distribution Rights for Virax Biolabs' Mpox (formerly Monkeypox) Virus Real-Time PCR Detection Kits
10:20am, Wednesday, 21'st Aug 2024
CHICAGO, IL / ACCESSWIRE / August 21, 2024 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM) , a diversified, vertically integrated global healthcare group engaged in innovative R
WHO Declares Monkeypox Public Emergency: 5 Mpox Stocks to Watch
12:11pm, Monday, 19'th Aug 2024
Is the next pandemic here. With health officials declaring Monkeypox a public health emergency, investors need to be watching Monkeypox-related stocks.
Why Is Virax Biolabs (VRAX) Stock Down 15% Today?
08:31am, Friday, 07'th Jun 2024
Virax Biolabs (NASDAQ: VRAX ) stock is down on Friday after the biotechnology company's shares underwent a massive rally yesterday. That saw shares of VRAX stock close out the prior day of trading up
Why Is Virax Biolabs (VRAX) Stock Up 115% Today?
07:55am, Thursday, 06'th Jun 2024
Virax Biolabs (NASDAQ: VRAX ) stock is rocketing higher on Thursday morning alongside heavy pre-market trading of the biotechnology company's shares. The heavy trading of Virax Biolabs stock has more
LONDON , April 25, 2024 /PRNewswire/ -- Virax Biolabs Group Limited (NASDAQ: VRAX) ("Virax" or the "Company"), an innovative biotechnology company focused on the detection of immune responses and diag
Virax Biolabs to Participate at ESCMID Global 2024
07:30am, Tuesday, 16'th Apr 2024
LONDON , April 16, 2024 /PRNewswire/ -- Virax Biolabs Group Limited (NASDAQ: VRAX) ("Virax" or the "Company"), an innovative biotechnology company focused on the detection of immune responses and dia
Virax Biolabs Announces Receipt of NASDAQ Notification Letter Regarding Minimum Bid Price Deficiency
04:30pm, Friday, 15'th Mar 2024
LONDON , March 15, 2024 /PRNewswire/ -- Virax Biolabs Group Limited (NASDAQ: VRAX) ("Virax" or the "Company"), an innovative biotechnology company focused on the detection of immune responses and diag
Penny Stocks To Buy Before 2024? 3 For Your Watch List Now
04:57pm, Wednesday, 27'th Dec 2023
Penny stocks, defined as stocks that trade for less than $5 per share, can be appealing to investors due to their low prices and potential for large percentage gains. However, penny stocks also carry
LONDON , Dec. 21, 2023 /PRNewswire/ -- Virax Biolabs Group Limited (NASDAQ: VRAX) ("Virax" or the "Company"), an innovative biotechnology company focused on the detection of immune responses and diag
Virax Biolabs' CEO James Foster Issues Letter to Shareholders
07:30am, Monday, 18'th Dec 2023
LONDON , Dec. 18, 2023 /PRNewswire/ -- Virax Biolabs Group Limited ("Virax" or the "Company") (Nasdaq: VRAX), today announced that Mr. James Foster, Chief Executive Officer of Virax, has issued a l
